Project Grant K18DA059913
Award Date
9/30/23
Completion Date
9/29/25
Dollars Obligated
$564K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
The General Hospital Corporation's Research Management Division, doing business as Massachusetts General Hospital (MGH), received a $474,783 federal Project Grant (R56AT011869) from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310). The award supports the adaptation and pilot testing of a remote mind-body resiliency group intervention to promote resilience among English and Spanish-speaking parents of children with learning and attentional disabilities...
The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $577,094 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Redirecting Viral Immunity to Eradicate Low Tumor Mutation Burden Lung Cancers." The award period runs from Aug 31, 2023 to Aug 29, 2025. As a leading academic medical center and research institution, MGH utilizes its...
The National Institute of Mental Health (NIMH) awarded a 4-year, $213,369 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to support mentoring activities and patient-oriented research (POR) on suicide risk processes among youth and young adults. The funding will provide the Principal Investigator, a clinical psychologist at MGH and Harvard Medical School, with 30% protected time to expand...
The federal Project Grant award of $799,986.00 was provided by the U.S. Department of Health and Human Services' Health Resources and Services Administration (HRSA) under the Mental and Behavioral Health Education and Training Grants program (CFDA 93.732). The award, effective July 1, 2025 through June 30, 2030, supports The General Hospital Corporation (doing business as Massachusetts General Hospital) in developing and expanding an Addiction Medicine Fellowship program. The goal of the program...
The Massachusetts General Hospital (MGH) Substance Use Disorder Initiative is a $749,939 Project Grant awarded by the U.S. Department of Justice Office of Juvenile Justice and Delinquency Prevention under the Opioid Affected Youth Initiative (CFDA 16.842). The initiative will provide multidisciplinary, trauma-informed, dyadic-based, longitudinal medical and mental healthcare at MGH's HOPE Clinic, aimed at reducing the intergenerational transmission of substance use and minimizing future juvenile...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $425,636 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct patient-oriented substance use and smoking cessation research in the context of HIV treatment and prevention. The key activities funded under this 5-year award include: 1) Mentoring junior researchers (pre- and post-doctoral fellows,...
The federal Project Grant award in the amount of $999,940.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "DEVELOPMENT OF IMAGING OUTCOME MEASURES OF NEUROPROTECTION IN MULTIPLE SCLEROSIS USING ULTRA-HIGH GRADIENT DIFFUSION MRI". The award period is from June 1, 2024 to May 31, 2027. Through this grant, MGH...
The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), has been awarded a $1,000,236.00 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, effective April 1, 2024 through March 31, 2028, will fund research to "UNLOCK THE CTDNA MUTATIONAL PATTERNS FOR EARLY CANCER DETECTION AND NONINVASIVE BIOMARKERS." As a leading academic medical center and research...
The Department of the Army Medical Command, through the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded a $1,498,368 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), with a performance period from August 1, 2024 to July 31, 2027. The grant supports research to elucidate the molecular mechanisms of tumor-immune dynamics and evolution in response to radiation, in order to optimize treatment of high-...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,644,309 project grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct advanced biomedical research focused on "FUNCTIONAL MOLECULAR NETWORKS MODIFYING HIF2A ACTIVITY IN VHL TUMORS". The grant, awarded on February 1, 2025, will support MGH's innovative research efforts to transform healthcare for military service members,...